Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

BBIOBBIO
12 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in BRIDGEBIO PHARMA INC

WELLINGTON MANAGEMENT GROUP LLP holds 5.3M shares of BBIO (BRIDGEBIO PHARMA INC), worth $395.4M as of 2026-Q2. The position was increased (+113.7% shares). BBIO represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$395.4M

Current Shares

5.3M

Total Value Change

+$358M

Total Shares Change

+3.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.3M
+113.7%
$395.4M0.1%$74.48
50
2026-Q1
Increased
2.5M
+5.8%
$184.5M0.0%$74.26
32
2025-Q4
Increased
2.3M
+130.4%
$179.7M0.0%$76.49
49
2025-Q3
Increased
1M
+1698.5%
$52.9M0.0%$51.94
47
2025-Q2
Decreased
56,669
-5.6%
$2.4M0.0%$43.18
0
2025-Q1
Decreased
60,011
-7.4%
$2.1M0.0%$34.57
0
2024-Q4
Decreased
64,807
-6.9%
$1.8M0.0%$27.44
0
2024-Q3
Decreased
69,586
-95.3%
$1.8M0.0%$25.46
0
2024-Q2
Decreased
1.5M
-4.7%
$37.2M0.0%$25.33
0
2024-Q1
Increased
1.5M
+3.1%
$47.7M0.0%$30.92
30
2023-Q4
Increased
1.5M
+5.3%
$60.4M0.0%$40.37
31
2023-Q3
New
1.4M
-
$37.4M0.0%$26.37
40

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used